CTLA4 and head and neck squamous cell carcinoma: These results from the correlation analysis suggested that HNSCC patients with lower CRRSs had more activation of immune-related processes and a better response to PD-1/CTLA4 inhibitor therapy; nevertheless, higher CRRSs may lead to mutation, metastasis, and immunosuppression.